Evidence map›Paper›PMID 34214752›Full record

ArticleBioorganic chemistry2021

New quinoline-triazole conjugates: Synthesis, and antiviral properties against SARS-CoV-2.

Israa A Seliem, Siva S Panda, Adel S Girgis, Yassmin Moatasim, Ahmed Kandeil, Ahmed Mostafa, Mohamed A Ali, Eman S Nossier, Fatma Rasslan, Aladdin M Srour and 4 more

Abstract read
In one paragraph

Article in Bioorganic chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Design, synthesis, characterization,Future medicinal chemistry · 2025
    Article
  7. Review
  8. Turkish journal of pharmaceutical sciences · 2025
    Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Dual action of epigallocatechin-3-gallate in virus-induced cell Injury.Journal, genetic engineering & biotechnology · 2023
    Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Israa A SeliemDepartment of Chemistry and Physics, Augusta University, Augusta, GA 30912, USA; Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt.
Siva S PandaDepartment of Chemistry and Physics, Augusta University, Augusta, GA 30912, USA. Electronic address: sipanda@augusta.edu.
Adel S GirgisDepartment of Pesticide Chemistry, National Research Centre, Dokki, Giza 12622, Egypt.
Yassmin MoatasimCenter of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt.
Ahmed KandeilCenter of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt.
Ahmed MostafaCenter of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt.
Mohamed A AliCenter of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt.
Eman S NossierDepartment of Pharmaceutical Medicinal Chemistry and Drug Design, Faculty of Pharmacy (Girls), Al-Azhar University, Cairo, Egypt.
Fatma RasslanDepartment of Microbiology and Immunology, Faculty of Pharmacy (Girls), Al Azhar University, Cairo, Egypt.
Aladdin M SrourDepartment of Therapeutic Chemistry, National Research Centre, Dokki, Giza 12622, Egypt.
Rajeev SakhujaDepartment of Chemistry, Birla Institute of Technology and Science, Pilani, India.
Tarek S IbrahimDepartment of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Zakaria K M Abdel-SamiiDepartment of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt.
Amany M M Al-MahmoudyDepartment of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

At present therapeutic options for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are very limited. We designed and synthesized three sets of small molecules using quinoline scaffolds. A series of quinoline conjugates (10a-l, 11a-c, and 12a-e) by incorporating 1,2,3-triazole were synthesized via a modified microwave-assisted click chemistry technique. Among the synthesized conjugates, 4-((1-(2-chlorophenyl)-1H-1,2,3-triazol-4-yl)methoxy)-6-fluoro-2-(trifluoromethyl)quinoline (10g) and 6-fluoro-4-(2-(1-(4-methoxyphenyl)-1H-1,2,3-triazol-4-yl)ethoxy)-2-(trifluoromethyl)quinoline (12c) show high potency against SARS-CoV-2. The selectivity index (SI) of compounds 10g and 12c also indicates the significant efficacy compared to the reference drugs.

Indexed as

COVID-19 Drug TreatmentAntiviral AgentsClick ChemistryHumansMolecular Docking SimulationQuinolinesSARS-CoV-2TriazolesAntiviral AgentsQuinolinesTriazolesClick chemistryMolecular dockingQuinolineSARS-CoV-2Triazole

Identifiers

PMID34214752
PMCPMC8219945

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.